Trial intelligence / Profile preview

Tenofovir and Emtricitabine in HIV/HBV Co-infection

NCT00476463Phase 2Completed

Sponsor
HIV-NAT
Start
Apr 2005
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tenofovir disoproxil fumarate in hepatitis B (HBV), human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Apr 2005; status: completed.

02

Drugs

tenofovir disoproxil fumarate
03

Conditions

hepatitis B (HBV)human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00476463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00476463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call